Avoro Capital Advisors LLC Vera Therapeutics, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
A detailed history of Avoro Capital Advisors LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 4,309,590 shares of VERA stock, worth $197 Million. This represents 2.87% of its overall portfolio holdings.
Number of Shares
4,309,590
Previous 4,309,590
-0.0%
Holding current value
$197 Million
Previous $156 Million
22.14%
% of portfolio
2.87%
Previous 2.13%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$180 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$153 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$135 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$128 Million11.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$118 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.24B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...